Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.

Kenji Watanabe Fumihito Hirai Kiyonori Kobayashi Ken Takeuchi Shinsuke Kurosu Katsutoshi Inagaki Ken-Ichi Iwayama Makoto Naganuma

Published in: Journal of gastroenterology and hepatology (2024)

A BID budesonide administration regimen is preferred to increase the probability of early response and, following endoscopic remission, a better prognosis after stopping treatment.

Keyphrases

ulcerative colitis
ultrasound guided
disease activity
physical activity
combination therapy
endoscopic submucosal dissection